G'day Jaggin, maybe this is a rose coloured glasses thing but I actually find the disclosure quite positive and in line with the way that Baker carries himself and this company - he's a straight shooter.
First the first time ever in the history of bio-spec companies you have these guys coming out and saying we're not happy with some technical issues associated with the contract research orgs in-mouse trials and that they want the trial to be repeated. Good on them. Good quality control and good science by my read.
G'day Jaggin, maybe this is a rose coloured glasses thing but I...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.005(4.00%) |
Mkt cap ! $126.0M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $92.22K | 749.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 370550 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 134745 | 7 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 12.5¢ | 12.5¢ | 12.5¢ | 104495 | ||
| Last updated 14.23pm 10/05/2024 ? | |||||
| ALA (ASX) Chart |